L-asparaginase (ASNase) is a therapeutic enzyme used to treat acute lymphoblastic leukemia. Currently, the most widely used ASNases are originated from bacteria. However, owing to the adverse effects of bacterial ASNases, new resources for ASNase production should be explored. Fungal enzymes are considered efficient and compatible resources of natural products for diverse applications. In particular, fungal species belonging to the genus Trichoderma are well-known producers of several commercial enzymes including cellulase, chitinase, and xylanase. However, enzyme production by marine-derived Trichoderma spp. remains to be elucidated. While screening for extracellular ASNase-producing fungi from marine environments, we found four strains showing extracellular ASNase activity. Based on the morphological and phylogenetic analyses using sequences of translation elongation factor 1-alpha (tef1α), the Trichoderma isolates were identified as T. afroharzianum, T. asperellem, T. citrinoviride, and Trichoderma sp. 1. All four strains showed different ASNase activities depending on the carbon sources. T. asperellem MABIK FU00000795 showed the highest ASNase value with lactose as a carbon source. Based on our findings, we propose that marine-derived Trichoderma spp. are potential candidates for novel ASNase production.

L-아스파라기나제는 급성 림프모구백혈병 환자에서 사 용이 증가하는 약물로, 췌장염은 이 약제의 중요한 합병증 중 하나이며, 항암화학치료 중 이에 대한 주의가 필요하다. 급성 췌장염은 드물지만 치명적 합병증인 괴사성 췌장염 으로 진행할 수 있으며 빠른 진단과 적절한 처치가 중요하다. 본 증례는 괴사성 췌장염에 동반된 췌관 누출 그리고 췌장가성낭이 경유듀적 췌관 스텐트 삽입으로 호전되었던 증례이다. 향후 이러한 L-아스파라기나제 유발 췌장염 및 췌관 누출의 치료를 위한 다양한 접근 및 안전성에 대해 추가적인 연구가 요구된다.